Robert A Beardsley insider trades

Open-market stock purchases and sales by Robert A Beardsley, Director at Arbutus Biopharma Corp, from SEC Form 4 filings since Nov 12, 2019.

Recent trades

DateStockTradeValue
Oct 1, 2026ABUS Arbutus Biopharma CorpSold (not open market)$89.7K
Sep 18, 2026ABUS Arbutus Biopharma CorpSold (not open market)$502K
Sep 18, 2026ABUS Arbutus Biopharma CorpBought (not open market)—
Sep 18, 2026ABUS Arbutus Biopharma CorpBought (not open market)—
Jun 8, 2026ABUS Arbutus Biopharma CorpBought (not open market)—

Companies traded

  • ABUS Arbutus Biopharma Corp: other filings, last Oct 1, 2026
  • GRTX Galera Therapeutics, Inc: other filings, last Feb 25, 2023

Get free alerts when Robert A Beardsley files a new trade →